BioResonance Therapy

Purported Benefits, Side Effects & More

BioResonance Therapy

Purported Benefits, Side Effects & More
BioResonance Therapy

Common Names

  • Electrodermal testing
  • Bio-physical information therapy
  • BIT; Bio-energetic therapy; Energy medicine
  • Vibrational medicine

For Patients & Caregivers

Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.

What is it?

Bioresonance therapies are based on unproven theories. They are not recommended for preventing or treating cancer.

Bioresonance therapies and other therapies that use electronic devices claim to both diagnose diseased internal organs and "normalize" the body's electrical properties and wave emissions. This is based on an unproven idea that unhealthy cells or organs emit altered electromagnetic waves, and that changing these waves back to normal will heal the body. The electronic devices are often promoted for treating cancer. None of the claims made by the promoters have been proven.

The American Cancer Society urges cancer patients not to seek treatment with bioresonance or other electronic devices.

What are the potential uses and benefits?
  • To diagnose and treat allergies

    Clinical trials show that bioresonance therapy and electrodermal testing are not successful in diagnosing allergies.
  • To treat eczema

    A clinical trial in children showed that bioresonance therapy was not effective. In addition, European guidelines do not recommend bioresonance for atopic eczema.
  • To treat asthma

    No scientific evidence supports this use.
  • To treat cancer

    This use is not supported by clinical data.
  • To treat rheumatoid arthritis

    This claim is not backed by research.

For Healthcare Professionals

Brand Name
(Devices): Dermatron, Accupath 1000, Vega, Interro, Hubbard E-Meter, Electro-Acuscope 80, Qi Gong Machine
Clinical Summary

Bioresonance therapy, available in clinics in Europe, Mexico, Florida, and elsewhere in the US, is used to diagnose and treat cancer, allergies, arthritis, and chronic degenerative diseases. A variation known as electrodermal testing was developed as an aid in prescribing homeopathic remedies, and is used in Europe for the diagnosis of allergies. Bioresonance therapy is based on the claim that electromagnetic oscillations emitted by diseased organs and cancer cells vary from those emitted by healthy cells due to their differences in cell metabolism and DNA damage. No evidence supports these claims. Treatment may involve removal and replacement of dental alloys or amalgams, which are said to carry currents that “alter the body’s electromagnetic circulatory system.”

Clinical trials evaluating electrodermal testing show no reliability in diagnosing allergies (7). A randomized trial of bioresonance for the treatment of atopic dermatitis in children showed no efficacy (3). In addition, European guidelines do not recommend bioresonance for atopic dermatitis (10).

The Food and Drug Administration has prosecuted numerous purveyors of electrical devices for making unsubstantiated health benefit claims (9). The American Cancer Society advises patients not to seek treatment with unproved electronic devices (4).

Purported Uses and Benefits
  • Allergies
  • Asthma
  • Eczema
  • Cancer
  • Arthritis
Mechanism of Action

Bioresonance is based upon the unproved premise that electromagnetic oscillations emitted by damaged organs and cancer cells vary from those emitted by healthy cells due to their differences in cell metabolism and DNA damage. An electrical device supposedly detects these differences and can determine which organs are affected and “cancel out” their diseased signal via destructive wave interference (1) (2).

Electrodermal testing was developed as an aid in prescribing homeopathic remedies. Medicines are tested “to determine how well they resonate with the individual or how similar they are to the body frequencies needing enhancement to overcome an illness.” Practitioners claim the wave emission from homeopathic medicines or allergens is measured through the device and is modulated through the patient’s autonomic nervous system, influencing skin resistance (4) (6). No evidence supports any of these claims.

Some proponents claim the device naturally kills tumor cells by releasing “suppressed” tumor suppressor genes or attenuating overactive oncogenes. This hypothesis is untenable because of the irreversibility of most cancer-causing genetic mutations. An evaluation of one device found that a galvanic skin response of low resistance was not a reliable indicator of vertebral pathology, and that the device produced a low-resistance reading after 5 seconds of application to any point on the body (7) (8).

  1. New Hope Clinic.
  2. Barrett S. ’Electrodiagnostic’ devices. BioResonance Tumor Therapy. Quackwatch web site. Available at
    . Accessed February 25, 2021.
  3. Schoni MH, Nikolaizik WH, Schoni-Affolter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol 1997;112:238-46.
  4. American Cancer Society. Questionable methods of cancer management: electronic devices. Ca: Cancer J Clin 1994;44:115-27.
  5. Nansel DD, Jansen RD. Concordance between galvanic skin response and spinal palpation findings in pain-free males. J Manipulative Physiol Ther 1988;11:267-72.
  6. Royal FF, Royal DF. Homeopathy and EDT: upheld by modern science - with case histories. Am J Acupuncture 1992;20:55-66.
  7. Lewith GT, et al. Is electrodermal testing as effective as skin prick tests for diagnosing allergies? A double blind, randomized block design study. BMJ 2001;322:131-4.
  8. Krop J, et al. A double-blind comparison of electrodermal testing with serial dilution end-point titration and skin prick tests for allergy to house dust mite. Am J Acupuncture 1998;26:53-62.
  9. Federal Trade Commission. Bogus Cancer Cure Guru Settles FTC Charges. October 28, 2002. Accessed February 25, 2021.
  10. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. Jun 2018;32(6):850-878.
Email your questions and comments to [email protected].

Last Updated